Replies to post #99119 on Cytodyn Inc (CYDY)

[CI Ventures]

Since the last conference, NP had been pretty quiet.. no interviews or updates giving. If everyone listen in to the last conference.. NP stated that once the efficiency data is out, Cytodyn will immediate forward it to the FDA and request for emergency approval along with the 100 patients Phase 2b/3 DSMC progress (that's all the hints I needed). My guess is that NP had been informed by the legals to stay shut until reports are out (to avoid inside trading)... our Thursday conference is to confirm the efficiency endpoint and will be pushing for emergency approval, until then.. SP will not move much.